-
Mashup Score: 6Using a gene signature to predict cancer patient's response to chemotherapy agent cisplatin - 1 year(s) ago
Researchers at Cleveland Clinic have taken an important step in predicting which treatment will work for individual cancer patients.
Source: News-Medical.netCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5NewsDetails - 1 year(s) ago
Contact Rachel Darwin, Senior Manager, Public Relations darwin@nccn.org, 2676226624 Four Early-Career Cancer Researchers Earn Prestigious Annual Award from NCCN Foundation National Comprehensive Cancer Network’s…
Source: NCCNCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @NCCN: Four early-career cancer researchers earn prestigious annual award from NCCN Foundation. Learn more: https://t.co/UGZfk8kYtw #NCC…
-
-
Mashup Score: 0
“We found that if the patient has normal IsoPSA, he has only 1% of risk of developing clinically significant prostate cancer in a median follow-up time of 18 months,” says Nour Abdallah, MD.
Source: Urology TimesCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @cjweight: Dr. @NourAbdalllah discusses new research on IsoPSA for prostate cancer https://t.co/8M4hNh5eyT via @urologytimes Hey I know…
-
-
Mashup Score: 2Using Artificial Intelligence to Diagnose Kidney Cancer - 1 year(s) ago
Algorithm distinguishes between benign and malignant masses
Source: Consult QDCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @cjweight: Using Artificial Intelligence to Diagnose Kidney Cancer https://t.co/mZYX3qH4MC via @CleClinicMD Thanks to @ShepardDale for…
-
-
Mashup Score: 3
This is the largest series looking at the association between Decipher and unfavorable pathologic features in prostate cancer.Molecular subtyping and gene set enrichment identified candidate pathways that might drive the pathogenesis of these outcomes.
Source: European Urology FocusCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EurUrolFocus: Current Issue: Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate https://t.co/INf5sFqNvD…
-
-
Mashup Score: 11
Stereotactic ablative body radiotherapy (SABR) is associated with good oncological outcomes and a favourable toxicity profile in patients with localised renal cell carcinoma (RCC). Intriguing multimodality approaches, which include SABR in the operable setting, are emerging. In the context of metastatic RCC, SABR alone or in combination with systemic treatment has shown promising clinical…
Source: European UrologyCategories: Latest Headlines, Oncologists1Tweet-
RT @EUplatinum: Editor's Choice: The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma https://t.co/7yuijmEPOL @l…
-
-
Mashup Score: 15Epidemiology, Screening, and Prevention of Bladder Cancer - 1 year(s) ago
Globally, bladder cancer (BC) is the tenth most common cancer. Tobacco smoking is the principal risk factor and smoking cessation represents the most important disease prevention strategy. There is insufficient evidence to recommend routine BC screening in the general population.
Source: European Urology OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EurUrolOncol: Bladder Cancer Review: Epidemiology, Screening, and Prevention of Bladder Cancer https://t.co/MU1L7GvwtK @niyatilobo…
-
-
Mashup Score: 164th ASH Annual Meeting and Exposition: 101. Red Cells and Erythropoiesis, Excluding Iron II - 1 year(s) ago
Symposia: Red Cells and Erythropoiesis, Excluding Iron Oral and Poster Abstracts Oral Research, Fundamental Science, Translational Research, Genetic Disorders, genomics, bioinformatics, hematopoiesis, pediatric, Diseases, immunology, metabolism, Biological Processes, Technology and Procedures, molecular biology, Study Population, Human, omics technologies 243-245…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @MerlinNithyaG: Great talks again in the second Red Cells and Erythropoiesis session at ASH. https://t.co/70xF5XV015 Thankful for the op…
-
-
Mashup Score: 1Impact of HSD3B1 gene alterations on treatment response in patients with prostate cancer - 2 year(s) ago
Omar Mian, MD, PhD, Cleveland Clinic, Cleveland, OH, presents a trial that investigated whether HSD3B1 gene alteration modulates response to therapy in patie…
Source: YouTubeCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @CleClinic_GUMRC: Impact of HSD3B1 gene alterations on treatment response @DrOmarMian @CCLRI https://t.co/r1YuhWnRXI
-
-
Mashup Score: 3Best of Radiation Oncology 2022 - 2 year(s) ago
This half day virtual course will provide a topical, clinically based overview of current issues in radiation oncology.
Source: www.clevelandclinicmeded.comCategories: Latest Headlines, Oncologists1Tweet-
RT @DrJohnSuh: Please sign up for the 24th Annual Best of Radiation Oncology meeting https://t.co/0rvzbnOFup on December 3, 2022, which wil…
-
RT @CancerConnector: Good coverage of our recent paper https://t.co/rjY7jFdQrw